Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRights &iss. Regulatory News (RIII)

Share Price Information for Rights &iss. (RIII)

Share Price is delayed by 15 minutes
Get Live Data
2,190.00    10.00 (0.46%)
Bid:
2,160.00
Ask:
2,220.00
Spread: 60.00 (2.778%)
Market Cap: £103.34m
RIII Live PriceLast checked at - London Stock Exchange

Intraday Rights &iss. Share Chart

Share Repurchase Programme

27 Mar 2026 11:20

RNS Number : 4767Y
Rights and Issues Inv. Trust PLC
27 March 2026
 

Rights and Issues Investment Trust plc ('the Company')

LEI: 2138002AWAM93Z6BP574

12 month Share Repurchase Programme in accordance with Discount Management Policy

Following the passing of the Special resolution authorising the Company to buy back shares at the Annual General Meeting held on 26 March 2026, Rights and Issues Investment Trust plc announces that the share repurchase programme which lapsed at the conclusion of the Annual General Meeting in 2025 has been reinstated with immediate effect for a period of 12 months to 26 March 2027. Cavendish Capital Markets Limited ("Cavendish") has been authorised to repurchase ordinary shares of 25p each ("Shares") on its behalf and within certain pre-set parameters between 27 March 2026 and 26 March 2027 (the "Buyback Period").

The Directors of the Company confirm that they are satisfied that all inside information known to the Directors and the Company up to the date of this notice has been notified to a Regulated Information Service ("RIS"). Accordingly, the Company is not prohibited from granting this authority to Cavendish under the Corporate Broking Agreement.

Purchases of Shares during the Buy-Back Period shall be subject to the following overriding restrictions:

(i) the maximum number of Shares acquired shall not, in aggregate, exceed the authorities granted at the Company's annual general meeting in 2026.

(ii) the maximum value of Shares acquired during the Buy-Back Period shall not exceed, in aggregate, £12.0 million. The maximum value of Shares acquired during each calendar month of the Buyback Period shall not, in aggregate, exceed £1.0 million (and pro rata for part months). However, to the extent that the value of Shares acquired in any month (or part month) is lower than the maximum value for that month, such excess capacity shall be carried forward to the following month and increase the maximum value for the following month accordingly, and so on for subsequent months. For the avoidance of doubt, there shall be no limit to the number of times an excess can be carried forward, or the total amount of such excess;

(iii) the maximum price paid per Share shall be no more than the highest of: (i) 105% of the average middle market closing prices of the Shares for the 5 dealing days preceding the date of such purchase; (ii) the last independent trade price; and (iii) the highest current independent bid for the Shares when the purchase is carried out;

(iv) the price paid per Share shall not be more than 95 per cent. of Cavendish's estimate of the net asset value per Share of the Company at the time of each purchase; and

(v) no purchases are to be made on any dealing day when the Company appears on the Disclosure Table published by the Panel on Takeovers and Mergers.

The Company shall not (i) exercise any influence over how, when or whether Cavendish effects share repurchases or (ii) change the number of Shares, price or timing of the purchases.

 

Enquiries:

Cavendish Capital Markets Limited

Andrew Worne / Tunga Chigovanyika - Corporate Finance

+44 (0) 207 908 6000

Pauline Tribe - Sales

+44 (0) 207 908 6000

Apex Fund Administration Services (UK) Limited

cosec-uk@apexgroup.com

+44 (0) 1245 398950

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBBGDXCBDDGLR
Date   Source Headline
6th May 202511:59 amRNSNet Asset Value(s)
2nd May 202511:48 amRNSNet Asset Value(s)
1st May 202511:51 amRNSNet Asset Value(s)
30th Apr 202510:59 amRNSNet Asset Value(s)
29th Apr 202510:48 amRNSNet Asset Value(s)
28th Apr 202512:33 pmRNSNet Asset Value(s)
25th Apr 202511:41 amRNSNet Asset Value(s)
24th Apr 202512:00 pmRNSNet Asset Value(s)
23rd Apr 202511:50 amRNSNet Asset Value(s)
22nd Apr 202512:53 pmRNSNet Asset Value(s)
17th Apr 20251:57 pmRNSNet Asset Value(s)
16th Apr 202512:18 pmRNSNet Asset Value(s)
15th Apr 20252:14 pmRNSNet Asset Value(s)
11th Apr 202512:27 pmRNSNet Asset Value(s)
11th Apr 20257:00 amRNSCirc re. Notice of General Meeting
10th Apr 20251:28 pmRNSNet Asset Value(s)
9th Apr 20252:01 pmRNSNet Asset Value(s)
8th Apr 202512:26 pmRNSNet Asset Value(s)
7th Apr 202511:12 amRNSNet Asset Value(s)
4th Apr 202510:29 amRNSNet Asset Value(s)
3rd Apr 202511:29 amRNSNet Asset Value(s)
2nd Apr 20251:00 pmRNSNet Asset Value(s)
1st Apr 202512:48 pmRNSNet Asset Value(s)
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 202511:09 amRNSNet Asset Value(s)
28th Mar 20252:50 pmRNSNet Asset Value(s)
27th Mar 202512:55 pmRNSNet Asset Value(s)
26th Mar 202510:16 amRNSNet Asset Value(s)
25th Mar 202510:20 amRNSNet Asset Value(s)
25th Mar 20257:01 amRNSSuspension of Share Repurchase Programme
25th Mar 20257:00 amRNSResult of AGM
24th Mar 202512:22 pmRNSNet Asset Value(s)
21st Mar 20255:14 pmRNSTransaction in Own Shares
21st Mar 202512:12 pmRNSNet Asset Value(s)
20th Mar 20252:26 pmRNSNet Asset Value(s)
19th Mar 202510:14 amRNSNet Asset Value(s)
18th Mar 202511:38 amRNSNet Asset Value(s)
17th Mar 202510:32 amRNSNet Asset Value(s)
14th Mar 202510:13 amRNSNet Asset Value(s)
13th Mar 202510:37 amRNSNet Asset Value(s)
12th Mar 202511:21 amRNSNet Asset Value(s)
11th Mar 202512:13 pmRNSNet Asset Value(s)
10th Mar 20252:15 pmRNSNet Asset Value(s)
7th Mar 20255:59 pmRNSTransaction in Own Shares
7th Mar 20253:51 pmRNSDirector/PDMR Shareholding
7th Mar 202512:55 pmRNSNet Asset Value(s)
6th Mar 202511:29 amRNSNet Asset Value(s)
5th Mar 20252:03 pmRNSNet Asset Value(s)
4th Mar 202510:13 amRNSNet Asset Value(s)
3rd Mar 202511:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.